Private Management Group Inc
Source: SEC Form 13F · as of Mar 2026Private Management Group Inc holds 19 biotech & pharma companies tracked by BioSniper, totaling $150.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$150.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Organon & Co. (OGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| OGNOrganon & Co. | 4,374,108 | $26.2M |
| QDELQuidelOrtho Corp | 1,384,769 | $22.8M |
| TEVATeva Pharmaceutical Industries Limited | 710,398 | $21.4M |
| ELANElanco Animal Health Inc | 818,119 | $19.6M |
| JNJJOHNSON & JOHNSON | 58,846 | $14.4M |
| BHCBausch Health Companies Inc. | 1,703,511 | $9.2M |
| PMPhilip Morris International Inc | 53,625 | $8.9M |
| ABBVAbbVie Inc. | 32,983 | $7.2M |
| CORCencora Inc. | 20,041 | $6.3M |
| OABIOmniAb Inc. | 2,429,166 | $3.8M |
| MRKMerck & Co., Inc. | 22,402 | $2.7M |
| PFEPFIZER INC | 82,137 | $2.3M |
| ABTABBOTT LABORATORIES | 21,191 | $2.2M |
| COYACoya Therapeutics, Inc. | 369,096 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 20,586 | $1.2M |
| LLYELI LILLY & Co | 609 | $560K |
| AMGNAMGEN INC | 1,454 | $512K |
| GNLXGENELUX Corp | 11,333 | $27K |
| CGTXCOGNITION THERAPEUTICS INC | 24,000 | $18K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.